Drug Profile
Typhoid vaccine Vi polysaccharide - Finlay Institute
Alternative Names: vax-TyVi; Vi polysaccharide typhoid vaccine - Finlay InstituteLatest Information Update: 17 Nov 2014
Price :
$50
*
At a glance
- Originator Finlay Institute of Cuba
- Developer Finlay Vaccine Institute
- Class Bacterial vaccines; Polysaccharides
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Typhoid
Most Recent Events
- 12 Nov 2014 Launched for Typhoid (Prevention; in adults and children) in Cuba (IM) prior to November 2014